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Abstract.  We characterized nine monoclonal antibod- 
ies that bind to the heavy chain of Acanthamoeba 
myosin-IA.  Eight of these antibodies bind to myosin- 
IB and eight cross-react with Acanthamoeba myosin-II. 
All but one of the antibodies bind to a  30-kD 
chymotryptic peptide of myosin-IA that derives from 
the COOH terminus  of the molecule, and to tryptic 
peptides as small as  17 kD, hence these epitopes are 
clustered closely together on the heavy chain.  None of 
the antibodies prevent heavy chain phosphorylation by 
myosin-I heavy chain kinase.  One antibody inhibits  the 
K+-EDTA  ATPase activity and  three antibodies inhibit 
the actin-activated Mg÷÷-ATPase activity of myosin-I 
under the set of conditions that we tested. When 
fluorescent antibody staining  of both whole cells and 
isolated nuclei is done,  several of these monoclonal 
antibodies react strongly with nuclei.  These antibodies 
also stain the cytoplasmic matrix,  especially the cortex 
near the plasma membrane.  All nine of the 
monoclonal antibodies bind to polypeptides of 30-34 
kD that are highly enriched in nuclei isolated from 
Acanthamoeba.  There is no myosin-I in the isolated 
nuclei,  so the 30-34-kD polypeptides, not myosin-I, 
are responsible for the nuclear staining. 
VER since it was discovered in Acanthamoeba  (24), 
myosin-I has been a fascinating enigma.  Unlike con- 
ventional  myosins,  including  myosin-II from Acan- 
thamoeba (21, 26), the myosin-I isozymes (IA and IB; refer- 
ence 23) are globular proteins consisting of only single heavy 
chains and one or two light chains (4, 23, 24). The myosin-I 
isozymes have little (10, 17) or no (4) tail, so that they do not 
polymerize to form conventional bipolar filaments like other 
myosins (24, 25).  On the other hand,  myosin-I  does have 
Ca  ++ and K+-EDTA ATPase activity similar to that of mus- 
cle myosin (24), binds reversibly to actin filaments  (10, 22, 
25) and, when phosphorylated on the heavy chain (22), pos- 
sesses actin-activated  ATPase activity (2, 22, 25). Myosin-I 
can propel plastic beads along actin filaments (4) and causes 
superprecipitation of actin filaments (9). Indirect fluorescent 
antibody  staining  with  polyclonal  antibodies  to  myosin-I 
showed that myosin-I is localized throughout the cytoplasm, 
but is especially abundant in the cortex of the amoeba (11). 
Until recently there was uncertainty regarding  the existence 
of myosin-I in any other cell type, but this has been resolved 
with the isolation of a similar  enzyme from the slime mold 
Dictyosteliura  discoideum (6). 
In  the  present  study,  we characterized  nine  antibodies 
(eight originally  described by Kiehart et al.; reference 17), 
including  one that  inhibits  the K+-EDTA ATPase  activity 
and  three that  inhibit  the actin-activated  Mg  ++ ATPase  of 
myosin-I.  It is of equal interest that  we show here that all 
of these antibodies to myosin-I  also bind to polypeptides of 
30-34 kD that are localized in the nucleoplasm. These nu- 
clear polypeptides clearly bear some relationship to myosin- 
I,  since the two proteins  share  several  epitopes.  However, 
further studies (27; Rimm, D., and T. D. Pollard,  manuscript 
in preparation) have shown that the nuclear proteins are not 
fragments of myosin-I.  Adams and Pollard (1) have also used 
one of these antibodies to inhibit  the movement of Acan- 
thamoeba organelles  in a model system. 
Part of this work was presented at the 1984 Annual Meet- 
ing of the American Society for Cell Biology (12). 
Materials and Methods 
Materials 
ATE  dithiothreitol,  imidazole  (grade  I),  phenylmethylsulfonylfluoride 
(PMSF), sodium azide, polylysine, and benzamidine were purchased from 
Sigma Chemical Co.  (St.  Louis,  MO).  [32p]ATP was  from Amersham 
Corp. (Arlington Heights, IL).  Reagent  grade chemicals were from J. T. 
Baker Chemical Co.  (Phillipsburg, N J).  Rhodamine-labeled goat anti- 
mouse Ig was from Cappel Laboratories (Cochranville, PA). Low gelling 
temperature Sea Plaque agarose was purchased from Marine Colloids Div., 
FMC Corp. (Rockland,  ME). Alpha-chymotrypsin and L-l-p-tosylamino-2- 
phenylethyl chloromethyl ketone (TPCK)-trypsin  were  purchased from 
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Removawells (Dynatech Laboratories, Inc., Alexandria, Va) were used for 
solid-phase binding assays. 
Cell Culture 
Acanthamoeba  castellanii  was grown in 15-liter aerated cultures (24) with 
a yield of about 15 g/liter. 
Protein Purification 
Acanthamoeba  myosin-I was purified from 1 kg of cells using Albanesi's 
modification (2) of earlier methods (21, 23, 24). Most of the experiments 
were performed on a pool of  myosin-IA and -lB. Myosin-I was stored at 4°C 
in 10% glycerol, 100 mM KCI, 1 mM dithiothreitol, 3 mM sodium azide, 
and 20 mM imidazole (pH 7.5). Acanthamoeba  myosiu-I heavy chain kinase 
was purified by the method of Hammer et al. (13) without final chromatogra- 
phy on histone-Sepharose. Actin was purified from rabbit skeletal muscle 
(20)  by Dr. Masahiko Sato (Johns Hopkins Medical School). 
Antibody Production 
Detailed methods for antibody production and purification are described by 
Kiehart et al. (17). Briefly,  mice were immunized and boosted with 20 I.tg 
of native myosin-I. Hybridoma cells secreting antibodies to myosin-I were 
detected by a solid-phase binding assay, cloned twice, and grown as ascites 
tumors in mice. IgMs were purified by three cycles of low ionic strength 
precipitation and high ionic strength solubilization. IgGs were purified by 
chromatography on DEAE-cellulose. 
Antibody Characterization 
Methods for solid-phase  binding assays, competitive binding assays with an- 
tibodies labeled with 35S or  1251, and reaction of antibodies ('~10 ttg/ml in 
culture supernatants) with polypeptides transferred to nitrocellulose paper 
are given by Kiehart et al. (17). We also determined the dependence of anti- 
body binding to immobilized myosin-I on the concentration of 35S-labeled 
antibody (17). When plotted by the method of Scatehard, the data were lin- 
ear and the slope was taken as an approximation of the relative dissociation 
constant of the antigen-antibody complexes, although we fully understand 
that this analysis is complicated by the multivalency of the IgM antibodies 
and the immobilization of the myosin on plastic. 
Biochemical Methods 
Protein  concentrations were  measured  by  UV  absorbance  using  these 
extinction coefficients: E 29°  =  0.62  cm: • mg  -1  for  actin,  E 2s°  =  0.65 
cm  2 • mg  -1 for myosin-l, and E 2s° =  1.4 cm  2 • mg  -l for mouse immuno- 
globulins. The Bradford assay (5) with ovalbumin as the standard was used 
to estimate the protein concentration in crude samples. Gel electruphoresis 
and blotting procedures are described by Kiehart et al.  (17).  K+-EDTA 
ATPase assays were done according to Pollard and Korn (24). The condi- 
tions for actin-activated ATPase assays were 4 mM MgC12, 1 mM ATE 10 
mM KC1, 20 mM imidazole (pH 7.5), and 2 IXM actin at 30°C. Phosphoryla- 
tion of the myosin-I heavy chain was carried out in 4  mM MgCI2,  1 m_M 
[~-32p]ATP, 50 mM KCI, 20 mM imidazole (pH 7.5),  and evaluated by gel 
electrophoresis and autoradiography. 
(prepared fresh from paraformaldehyde), 1.5 % glucose, 50 mM NaCI, and 
20 mM sodium phosphate (pH 7.0). After a brief rinse in buffer, the cells 
were permeabilized in acetone at  -20"C for 30 s, then immediately re- 
hydrated in a solution of 2 mg/ml Knox gelatin, 150 mM NaC1,  10 mM so- 
dium phosphate, pH 7.5, (gelatin-PBS) containing 1 mM ethanolamine. The 
cells were rinsed twice in gelatin-PBS and then incubated for 1 h at 22°C 
with specific monoelonal antibody diluted to a concentration of 10 ttg/ml 
with gelatin-PBS. After a  brief rinse in gelatin-PBS, the cells were in- 
cubated for 1 h at 22°C with rhodamine-labeled goat anti-mouse Ig diluted 
to 50 I~g/ml with gelatin-PBS. After three brief rinses, all coverslips were 
mounted with Mowel mounting agent and examined with a Leitz Orthoplan 
microscope. Controls for all antibody staining experiments included: (a) 
monoclonal antibody to myosin-H;  (b) monoclonal antibody to chicken 
skeletal muscle myosin (17); and (c) rhodamine-labeled goat anti-mouse Ig 
alone. 
Antibody staining of isolated nuclei was similar to that described above 
for whole Acanthamoeba  with these modifications: (a) nuclei were placed 
on clean glass coverslips (no polylysine); and (b) nuclei were permeabilized 
for 5 min in 0.1% Triton X-100 in gelatin-PBS rather than acetone at - 20°C. 
Frozen sections were prepared as described by Tokyuasu (28).  Packed 
cells (200 p.l) were lightly fixed in 2% formaldehyde, 1.5% glucose, 50 mM 
NaCI, and 20 mM sodium phosphate (pH 7.0), washed, and then mixed with 
1 ml of low gelling temperature Sea Plaque agarose at 37°C degrees. After 
the agar cooled to form a  hard pellet containing the cells, it was cut into 
small pieces, washed in PBS, infiltrated with 2.3 M sucrose, and plunged 
into liquid nitrogen. Half-micron sections were made with glass knives 
using a microtome equipped with a cryokit (model MT-2B; Dupont Co., 
Sorvall  Instruments Div.,  Newtown,  CT).  After sectioning, cells  were 
treated in gelatin-PBS containing 1 mM ethanolamine, washed in gelatin- 
PBS, stained, and observed as described above. 
Results 
Production of  Monoclonal Antibodies to Myosin-I 
We cloned nine hybridoma cell lines secreting monoclonal 
antibodies to purified myosin-I and then designated each an- 
tibody as M1.X, where X is an integer from one to nine (Ta- 
ble I). Production of eight of these antibodies was initially 
described by Kiehart et al. (17). Most of the M1.X's are IgMs 
and all appear to have a high affinity for myosin-I (Table I) 
Table L Properties of  Monoclonal Antibodies to 
Acanthamoeba Myosin-I 
Binding reactions 
Myosin-  Myosin-  Myosin-  Nuclear 
Antibody Isotype  ~  IA  IB  II  proteins 
MI.1  IgG2B 
MI.2  IgM 
Isolation of  Nuclei  MI.3  IgM 
30 g of  packed cells from Acanthamoeba  were mixed with 2 vol of  extraction  M1.4  IgM 
buffer containing 8.5%  sucrose, 25 mM KC1, 4  mM MgC12, 5  mM di-  M1.5  IgM 
thiothreitol, 18 ttg/ml benzamidine, 1 mM PMSF and 30 mM "Iris, (pH 7.5),  MI.6  IgM 
homogenized in a glass Dounce homogenizer, and centrifuged at 2,000 rpm  M1.7  IgG2B 
for 10 min at 4°C. The soft pellet was resuspended to a total volume of 60  M1.8  IgGl 
ml with extraction buffer (above)  and then homogenized again to separate  M1.9  IgM 
vesicles from the nuclei. Buffer containing 78.2% sucrose (2.3 M), 25 mM 
KCl, 4 mM MgCI2 and 30 mM Tris, (pH 7.5) was added to a  volume of 
180 ml. Nuclei were collected by centrifugation at 20,000 rpm for 60 min 
in a rotor (model SW 28; Beckman Instruments, Inc., Fullerton, CA) at 
4°C, through a  5-ml cushion of the 2.3-M sucrose buffer (above). 
Antibody Staining of Whole Cells and Isolated Nuclei 
Acanthamoeba  were allowed to spread for 1 h on polylysine-coated cover- 
slips and then fixed for 15 min in a  solution containing 2% formaldehyde 
nM 
0.05  +  +  -  + 
0.02  +  +  +  + 
0.08  +  +  +  + 
0.24  +  +  +  + 
*  +  +  +  + 
0.08  +  +  +  + 
0.22  +  -  +*  + 
0.20  +  +  +  + 
0.13  +  +  +§  + 
Binding to myosin-IA, myosin-IB, and myosin-II was assessed by solid-phase 
antibody binding assays  with purified protein and by reaction  with purified 
polypeptides on nitrocellulose  blots of SDS gels. Binding to nuclear polypep- 
tides was tested on blots of nuclei run on SDS gels. The apparent dissociation 
constant (/~*) was determined by Scatchard  analysis  of solid-phase  binding 
data (17) using purified myosin-l. 
* MI.5 binds very weakly to denatured myosin-I and myosin-I that has been 
dried down on immulon wells,  so we could not evaluate its affinity. 
* M1.7 hinds to myosin-l] on solid-phase assays but not on blots. 
§ M1.9 hinds to myosin-II weakly on blots and not at all on solid-phase assays. 
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polypeptides of (A) whole cells, (B) a soluble protein fraction, and 
(C) isolated nuclei. Peptides were separated by SDS PAGE, trans- 
ferred to nitrocellulose  paper,  and  reacted  with  each antibody. 
Bound antibodies were detected with ~25I-goat  anti-mouse Ig and 
autoradiography.  Antibodies,  (lane 1) M 1.1; (lane 2) M 1.2; (lane 
3) M1.3;  (lane 4) M1.4; (lane 5) Control IgG; and (lane 6) con- 
trol  IgM. The mobilities  of myosin-I (130  kD), myosin-II (175 
kD), and the cross-reactive  nuclear protein (30 kD) are indicated 
on the left along with the molecular masses in kilodaltons of sever- 
al  standards.  The heavy chains  of myosin-IA and -IB were not 
resolved  on these gels. 
Antibody Staining of One-dimensional 
Tryptic Peptide Maps 
When reacted with a chymotryptic digest of myosin-IA con- 
sisting primarily of intact heavy chain (130 kD), a  100-kD 
peptide from the NH2-terminal region, and a 30-kD peptide 
from the COOH-terminal region (3, 10), all of the antibodies 
(except  1.5  that bound  weakly) bound  to  the  intact heavy 
chain and to the 30-kD peptide (Fig. 2). M1.7 bound only to 
these two peptides.  The other antibodies bound weakly to 
peptides of 72 and 88 kD that do not appear on the stained 
gel. They also bound weakly to a peptide of 100 kD that we 
doubt, on the basis of the intensity of these bands relative to 
the 130-kD bands, is the major 100-kD peptide that appears 
on the stained gel. These results show that MI.1, M1.2, M1.3, 
M1.4, M1.6, M1.7, M1.8, and M1.9 all bind within 30 kD of 
the  COOH terminus of the myosin-IA heavy chain.  M1.5 
bound only weakly to these blots, but reacted equally well 
with 130- and 100-kD bands. This is tentative evidence that 
M1.5  is the only antibody that binds to the major  100-kD 
judging  from the  low concentrations  of antibody required 
to  achieve half maximal binding  to  myosin-I immobilized 
on plastic.  Antibody M1.5 binds only weakly to denatured 
myosin-I or myosin-I that has been dried down on immulon 
wells, but it appears to have a high affinity for native myosin- 
I,  judging  from  its  effects  on  ATPase  activity  described 
below. 
Identification of  Proteins that Bind M1.X  Antibodies 
All  of the  M1.X  antibodies bind to myosin-IA and all but 
M1.7 bind to myosin-IB in both solid-phase binding assays 
(not shown) and on electrophoretic transfers of SDS gels to 
nitrocellulose (Figs.  1 and 2).  Even at high concentrations, 
no binding of M1.7 to myosin-IB was detected in either assay. 
When reacted with polypeptides from whole Acanthamoeba 
separated by gel electrophoresis, all nine M1.Xs bind to the 
130-kD heavy chain of myosin-I and all react at least weakly 
with one or two polypeptides of 30 and 34 kD (Fig.  1 A). 
Eight of the  nine M1.Xs  also bind to the  175-kD  heavy 
chains of myosin-II (Table I, Fig.  1; reference 17), although 
the strength of binding to myosin-II varies. MI.1 did not bind 
well on either blots or on solid-phase assays. M1.3 and M1.4 
bound  consistently  on  both  blots  and  solid-phase  assays. 
M1.7  bound  on  solid-phase assays but  not on blots.  M1.9 
bound weakly on blots but not on solid-phase assays. Judging 
from quantitative solid-phase assays over a range of antibody 
concentrations,  none  of the  M1.Xs  bind  to  myosin-II as 
strongly as they bind to myosin-I. 
The heavy chains of both myosin-I and myosin-II are pres- 
ent in the soluble protein fraction (Fig.  1 B) while the low 
molecular mass polypeptides are highly enriched in a puri- 
fied nuclear fraction (Fig.  1 C). 
Figure 2.  Reaction of monoclonal  antibodies  with chymotryptic 
fragments  of myosin-IA. Myosin-IA in  100  mM KCI,  10 mM 
Tris-HC1, pH 7.5,  1 mM dithiothreitol,  and 12.5% glycerol was 
digested for 30 min at room temperature with alpha-chymotrypsin 
at an enzyme/substrate  ratio of 1:100 (wt/wt).  Proteolysis was ter- 
minated  by the  addition  of an equal  volume of 2X  gel  sample 
buffer  at  100°C.  After gel  electrophoresis  and  electroblotting, 
individual  strips  of nitrocellulose  containing  alpha-chymotryptic 
peptides were reacted with  1 I.tg/ml monoclonal antibody.  Bound 
antibodies  were detected  with  ~zSI-goat  anti-mouse Ig and auto- 
radiography.  The first lane is a gel stained with Coomassie Blue. 
Lanes 1-9 are the autoradiograms of strips stained with antibodies 
M I. I-M 1.9. (The authors are extremely grateful to Dr. Joseph P. 
Albanesi of the National  Institutes  of Health, who prepared the 
peptides.) 
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of myosin-IA. The experimental  methods were identical to those 
in Fig. 2, except that TPCK-trypsin was used to digest the myosin. 
fragment, the part of the molecule with the nucleotide bind- 
ing site and regulatory phosphorylation site (3). 
Similar experiments with tryptic peptides (Fig. 3) confirm 
that  these  antibodies  bind  near  each  other  on  the  heavy 
chain, but are less informative regarding the location of this 
site along the heavy chain.  With the exception of M1.5,  all 
of the antibodies bind to a similar set of tryptic peptides of 
myosin-IA (Fig. 3). The major reactive peptides have molec- 
ular masses of 95,  27,  and  17 kD, as seen particularly well 
with M1.7 (Fig. 3). Note that most of the antibodies also bind 
to several peptides of 80-100 kD and to another peptide of 
50 kD. None of these peptides is a major band on the stained 
gel. None of the antibodies bind to a stable Coomassie Blue- 
stained peptide of ,~41 kD (Fig. 3), shown by Albanesi et al. 
(3) to contain a uridine triphosphate binding site, or to an- 
other major peptide with a  molecular mass of 73 kD. 
Localization  of  Binding Sites by 
Competitive Binding Assays 
We used competitive binding studies to establish the relation- 
ship between antibody binding sites. Most of the M1.X anti- 
bodies can interfere with the binding of each other to myosin- 
I (Fig. 4).  The matrix is incomplete because M1.5  binds so 
weakly in these assays. Based on this assay, only MI.1 and 
M1.9 can bind simultaneously to myosin-I, and therefore oc- 
cupy independent sites. 
It was previously established that M1.4 inhibits the bind- 
ing of M2.4,  M2.6,  M2.7,  and M2.26 to myosin-II (17) and 
new experiments confirm and extend this analysis of cross- 
reactivity. First,  antibodies M1.3,  M2.4,  M2.6,  M2.7,  and 
M2.26 strongly inhibit the binding of M1.4 to myosin-II, es- 
tablishing that this competition is reciprocal and confirming 
that the cross-reactive site is on the proximal part of the tail 
of myosin-II (18). Identical results were obtained on blots and 
solid-phase assays. Second, high concentrations of M1.5 in- 
hibit  the  binding  of radiolabeled  M2.1  to  myosin-II. The 
M2.1 epitope is located at the junction of the heads with the 
tail of myosin-II (18). M1.2,  M1.6, and M1.8 did not inhibit 
the  binding  of any of 21  radiolabeled M2.X  antibodies to 
myosin-II, so we do not yet know exactly where any of these 
M1.X antibodies bind to myosin-II. None of 50 M2.X anti- 
bodies bind to myosin-I on blots of crude cell extracts (16, 
17), nor do any of the M2.X antibodies specific for the prox- 
imal tail of myosin-II (M2.4,  M2.6,  M2.7,  M2.10,  M2.26) 
bind to purified myosin-I or compete with M1.4 for binding 
to myosin-I on blots or solid-phase assays. 
Effects of  Antibodies on Phosphorylation of  the 
Myosin-I Heavy Chain 
None of the antibodies tested (MI.1, M1.2, M1.5, M1.6, M1.7, 
and M1.8) prevented phosphorylation of the myosin-I heavy 
chain by the heavy chain kinase when present in a 10-fold ex- 
cess over the myosin-I and  incubated  with  [7-32p]ATP  for 
10 rain (data not shown). Gel electrophoresis of the products 
of this incubation also showed that none of these antibodies 
were contaminated with enough protease activity to cleave 
detectable amounts of myosin-I heavy chain. 
Effect of  Monoclonal Antibodies on ATPase Activity 
Antibody  M1.5  inhibits  the  K+-EDTA  ATPase  activity  of 
myosin-I in a concentration-dependent fashion (Fig. 5) with 
1251.[abele  d Antibodies 
M1.1  M1.2  M1.3  M1.4  M1.5  M1.6  M1,7  M1.8  M1.9 
M1.1  7  9  54  6  7  39  60 
M1,2  28  3  4  5  3  94  63  21 
M1.3  28  5  1  5  7  15  48  14 
=5 
o  M1,4  31  4  63  5  8  74  47  14 
M1.5  88  74  111  76  89  121  94  77  1:3 
M1,6  36  2  3  3  4  50  67  12 
-=  M1.7  57  11  38  7  61  50  41 
M1.8  4  2  2  4  3  15  6  12 
M1,9  104  3  2  6  5  36  54  10 
Figure 4. Competitive  binding assays.  Radioiodinated antibodies 
were competed with a 10-100-fold molar excess of unlabeled anti- 
bodies for binding to myosin-IA in the solid-phase assay (17). The 
fgures shown are counts bound corrected for nonspecific antibody 
binding and normalized to a value of 100 % established by samples 
with unlabeled control antibodies.  The activity of M1.7  was lost 
during iodination, so competition between M 1.7 and an excess of 
the other antibodies for binding to myosin-IA was tested with an 
indirect assay. The amount of M1.7 bound to the wells was mea- 
sured by ELISA using a goat anti-mouse IgG2B  coupled to horse- 
radish  peroxidase.  MI.1  is  also  an  IgG2H, so  it  could  not  be 
tested.  Similar  results  were  obtained  with  ~25I-labeled protein  A 
at pH 6.0 where it binds to IgG2ss but not IgM or IgG~. In con- 
trols,  the second reagents did not react with IgG~ or IgM mono- 
clonal antibodies. 
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per myosin molecule. Antibodies M1.2, M1.6, and a control 
IgM  (Fig.  5)  actually enhance the activity slightly,  while 
MI.1, M1.7, and M1.9 have no effect. Since none of the other 
IgG-type  or  IgM-type  antibodies  inhibit  the  K+-EDTA 
ATPase activity of myosin-I, and since M1.5 does not de- 
grade the myosin-I heavy chain, we think that the effect of 
M1.5 is due to an effect of antibody binding (rather than the 
action of a contaminant), in spite of the fact that an excess 
of antibody  is  required.  Perhaps  the  binding  of M1.5  to 
myosin-I is weak at the high ionic strength of the assay.  We 
could not produce enough purified M1.3, M1.4, or M1.9 for 
definitive experiments. 
When  tested at an actin concentration of 2  IxM,  M1.5, 
M1.6, and M1.8 all inhibit the actin-activated Mg  ++ ATPase 
of phosphorylated myosin-I in  a  concentration-dependent 
fashion (Fig. 6). This is the actin concentration that gives a 
peak of ATPase activity due to cross-linking of the actin illa- 
ments by myosin-I (2, 10). We did not test other aetin concen- 
trations. M1.5 is the most potent inhibitor, with 100% inhibi- 
tion at a molar ratio of less than one antibody site per myosin 
molecule. 50 % inhibition requires a molar ratio of ~0.6 for 
M1.6 and ~6 for M1.8. Even with a large excess of M1.8 there 
is  some residual activity. MI.2  weakly inhibits activity at 
very  high  concentrations.  Antibodies  MI.1,  M1.7, M2.2 
(control IgG), and control IgM (referred to as antidynein in 
reference 17) did not inhibit actomyosin-I ATPase activity. 
M1.3,  Mt.4, and M1.9 could not be tested. 
Fluorescent Antibody Staining 
Monoclonal antibodies MI.1, M1.7, and M1.8 (all IgGs) stain 
fixed cells in the same way. There is intense staining of the 
nucleus and lighter staining throughout the cytoplasm (Fig. 
7 A). In thin frozen sections (Fig. 7 B) it is clear that the nu- 
clear staining is strongest in the nucleoplasm, is not espe- 
cially intense at the nuclear envelope, and is weak in the 
nucleolus.  The sections also show that the  staining  in the 
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Figure 5. Effect of M1.5 on the K÷-EDTA ATPase activity of 61 
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Figure 6.  Effect of M1.2, M1.5,  M1.6, and M1.8 on the actin- 
activated  ATPase activity  of 61  nM  phosphorylated  myosin-I. 
The ratio of antibody to myosin is expressed  as moles of anti- 
body binding sites to moles of myosin.  The actin concentration 
was  2  txM. The activity  in  the  absence  of antibody  was  2.2 
lxmol • min  -~ • mg  -]. Control IgM and IgG monoclonal antibod- 
ies did not inhibit the activity. 
cytoplasm is most intense very near the plasma membrane, 
confirming the observation of Gadashi and Korn (11) regard- 
ing polyclonal antibodies that stained only the cytoplasm. 
Two monoclonal IgMs (M1.6 and M1.9) and an immunoglob- 
ulin fraction from a rabbit immunized with myosin-I (rabbit 
JH-6;  reference 17)  also  stain the  nucleus more intensely 
than the cytoplasm (not shown). 
Monoclonal antibodies to myosin-II, all IgGs, give a com- 
pletely different pattern of staining (Fig. 7 C).  These anti- 
bodies stain the cytoplasmic matrix diffusely. Organelles, in- 
cluding the nucleus and contractile vacuole, are unstained, 
and the cortex is no more fluorescent than other parts of the 
matrix. Cells stained with monoclonal IgG against muscle 
myosin or second antibody alone are not fluorescent. 
Isolated nuclei stain the same as nuclei inside cells (Fig. 
8). All three IgG monoclonal antibodies to myosin-I stain the 
nucleoplasm, while antibodies to myosin-II (Fig.  8,  inset) 
and control antibodies do not stain nuclei. 
Discussion 
Our results provide new  information about the relation of 
myosin-I  to  myosin-II  and  demonstrate  a  previously  un- 
• known structural homology between myosin-I and a protein 
located in the nucleus. The interpretation of these antibody 
cross-reactions depends on location of the epitopes on myo- 
sin-I,  so we will consider that first. 
Eight of the MI.X antibodies characterized here bind to 
sites on myosin-IA within 30 kD of the COOH terminus, as 
demonstrated by peptide maps (Fig. 2). These eight epitopes 
are within 17 kD of each other, since the antibodies all bind 
to a  17-kD tryptic peptide (Fig.  3).  With the exception of 
MI.1 versus M1.9 and MI.5 versus all others, all of the M1.Xs 
compete with each other for binding to myosin-I (Fig. 4). 
This is not surprising since the antibodies, especially the six 
IgMs,  are  considerably larger than  the  17-kD peptide,  so 
steric interference is to be expected. In our analysis of epi- 
topes on myosin-II (17), competitive binding was the most 
Hagen et al. Monoclonal  Antibodies  to Myosin-I  2125 Figure 7. Localization of myosin-I and myosin-II in Acanthamoeba  by indirect fluorescent  antibody staining.  Phase contrast and fluores- 
cence of the same areas are illustrated.  (A) Whole cells stained  with M 1.8.  This antibody stains both the nucleus (N) and the cytoplasm. 
(B) A 0.5-~m frozen section of Acanthamoeba  stained  with M1.8. The cytoplasmic staining  is strongest near the plasma membrane (ar- 
row).  The nucleolus (Nu) is not stained  as strongly as the nucleoplasm (N) (inset).  (C) Whole cells stained  with  M2.5.  Myosin-II is 
localized  diffusely throughout the cytoplasm in Acanthamoeba.  Note that myosin-II is not found in the nucleus (N) or contractile vacuole 
(CV).  Bar,  10 ~m. 
sensitive method for establishing  that any two sites are dis- 
tinct,  but most of the sites on myosin-I are so close.together 
that they are not distinguishable  by this method. 
Fortunately,  all of the M1.Xs have unique properties that 
are consistent with each binding to a distinct site on myosin- 
I. All of the antibodies except M1.7 bind to both myosin-IA 
and  myosin-IB, hence this  unique  MI.7 site  on myosin-IA 
differs from all of the other epitopes.  Only M1.5 inhibits the 
binding of M2.1 to myosin-II, so it must also be a unique epi- 
tope. M1.2, M1.3, and M1.4 all compete with each other for 
The Journal of Cell Biology,  Volume  103. 1986  2126 Figure 8. Isolated nuclei from Acanthamoeba stained indirectly with M1.8. Phase contrast and fluorescence of the same area are illustrated. 
Inset shows isolated nuclei stained with M2.5.  Bar,  10 p.m. 
binding to myosin-l, but they can be distinguished because, 
of these three, only M1.4 competes with the M2.4 family for 
binding to myosin-II and only M1.2 fails to inhibit the bind- 
ing of MI.4 to myosin-II. This is confirmed by reactions of 
the antibodies with tryptic peptides, since only M1.2 binds 
strongly to  a  6-kD peptide  (Fig.  3).  One  interpretation  of 
these results is that each antibody binds to a unique site and 
that these sites are located close to each other. Higher resolu- 
tion mapping of the sites will be necessary to confirm or re- 
fute this interpretation. 
Since myosin-IA and -IB share seven of these eight epi- 
topes, the sequences  of their COOH termini must be very 
similar, but not identical.  The detailed peptide maps of A1- 
banesi  et  al.  (3)  had  previously  established  that  the  se- 
quences of the  100-kD NH2-terminal regions of myosin-IA 
and -IB are different. 
Our work with antibodies (17; present report), and com- 
plementary  work on  primary structure  (14,  15)  and  func- 
tional  domains  (10),  shows  that  myosin-I is  more  closely 
related to myosin-II and to other myosins than was originally 
apparent (Fig.  9).  The myosin-II molecule can be divided 
into a  100-kD NH2-terminal fragment and a 30-kD COOH- 
terminal fragment. The NHz-terminal fragment has ATPase 
activity,  an  ATP-sensitive actin  binding  site  (10),  a  phos- 
phorylation site (3), and extensive sequence homology with 
the heads of other myosins (15). Like the heads of myosin-II, 
this part of myosin-I is not very antigenic; only six out of 50 
M2.Xs bind to the heads of myosin-II (16, 18, 19) and no more 
than one of the nine M1.Xs binds to the corresponding 100- 
kD fragment of myosin-I. In contrast, the region distal to the 
head-tail junction is the most antigenic part of myosin-II (16, 
18) and the corresponding part of myosin-I has the binding 
sites for eight of the nine M1. Xs. The existence of antibodies 
that bind to both the proximal part of the tail of myosin-II 
and to the 30-kD COOH-terminal region of myosin-I raises 
the question of possible homology in these parts of the two 
myosins.  There  are  at  least  common  epitopes,  but  close 
similarity is improbable, because the tails of all known con- 
ventional  myosins  (like myosin-II) are coiled coils of two 
parallel alpha-helical polypeptides, while myosin-I is com- 
posed  of a  single  heavy  chain.  A  single  heavy  chain  is 
unlikely  to  form a  parallel  coiled  coil.  Furthermore,  the 
COOH-terminal  region  of myosin-I has  an unprecedented 
ATP-insensitive binding site for actin filaments (10). 
Our most unexpected result is the cross-reactivity of all 
nine M1.Xs with a low molecular mass polypeptide in the nu- 
cleus. In our previous publication (17), we speculated that the 
low molecular mass peptides are  a  breakdown  product of 
myosin-I (17).  While  there  is  no  doubt  that  fragments of 
myosin-I can be present in crude extracts, we are confident 
that the cross-reactive nuclear proteins are not fragments of 
myosin-I, because polyclonal antibodies  raised against the 
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Figure  9.  Comparison  of myosin-I  (I)  and  myosin-II (II)  heavy 
chains. The polypeptides  are aligned on the left at their NH2 ter- 
minus.  Arrow  indicates  the  site of the chymotryptic  cleavage of 
myosin-I discovered by Fujisaki et al. (10). Shaded regions indicate 
the homologous, putative ATP binding regions sequenced by Ham- 
mer et al. (15). Stippled regions show the homologous regions that 
we have identified by antibody cross-reactivity, including the bind- 
ing sites of specific antibodies  indicated by numerals. 
Hagen et al.  Monoclonal  Antibodies  to  Myosin-I  2127 34-kD  protein  purified  from  the  nucleus  react  with  the 
30-34-kD nuclear proteins but not with purified myosin-I or 
other higher molecular mass polypeptides in whole cell sam- 
ples (17; Rimm, D., and T. D. Pollard, manuscript in prepa- 
ration). On the other hand, since the M1.X antibodies bind 
to  several  distinguishable  sites  on  myosin-I,  their  cross- 
reaction with the nuclear proteins suggests that there is sub- 
stantial homology between myosin-I and the nuclear pro- 
teins, rather than some sort of spurious cross-reactivity as 
previously noted for other monoclonal antibodies (7, 8, 24). 
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